Ranbaxy, Teva settle US antitrust claims - The Hindu BusinessLine
Case studies in Strategy: Teva | PPT
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Threat of Generic Copycat Comes Back to Nip at Teva - WSJ
Teva Pharmaceuticals - Wikipedia
Ranbaxy gets approval to sell generic Lipitor - nj.com
Teva Pharmaceuticals Ltd: A Global Leader in Generic Drugs | PDF | Generic Drug | Novartis
Fortune India: Business News, Strategy, Finance and Corporate Insight
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals - Wikipedia
 "Sun Pharma buys Ranbaxy from Japan's Daiichi")
Sun Pharma buys Ranbaxy from Japan's Daiichi
Ranbaxy, Teva settle New York antitrust drug claims
Ranbaxy vs Teva Pharmaceuticals | Comparably
Facilfarmacia. METOCLOPRAMIDE 5 MG (TEVA) 500 TB
Pfizer, Inc. v. Teva Pharms. USA, Inc., 05-1331 (Fed. Cir. Nov. 22, 2005) (Prost, J.)
Ranbaxy, Teva settle anti-competition claims in US - BusinessToday
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion - The New York Times
Ranbaxy forms pact with Teva to launch generic Lipitor in US
Ranbaxy launches generic Lipitor in Europe - Pharmafile
us market: Drugmakers Ranbaxy, Teva reach pact to compete in US market - The Economic Times
Ranbaxy-Sun Pharma merger to create world's fifth-largest generic drug firm - BusinessToday
 "Ranbaxy loses 180-day exclusivity on heartburn drug in US")
Ranbaxy loses 180-day exclusivity on heartburn drug in US
Teva's Ranbaxy Like Mess Builds Up in Mexico | Radio Compass Blog
Sun Pharma buys Ranbaxy from Japan's Daiichi
Teva Pharmaceuticals - Wikipedia
Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around (NYSE:TEVA) | Seeking Alpha
